Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown I. G., Chan C. S., Kelly C. A., Dent A. G., Zimmerman P. V. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation. Thorax. 1984 Apr;39(4):272–276. doi: 10.1136/thx.39.4.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Driscoll B. R., Taylor R. J., Horsley M. G., Chambers D. K., Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet. 1989 Jun 24;1(8652):1418–1420. doi: 10.1016/s0140-6736(89)90126-8. [DOI] [PubMed] [Google Scholar]
- Rebuck A. S., Chapman K. R., Abboud R., Pare P. D., Kreisman H., Wolkove N., Vickerson F. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med. 1987 Jan;82(1):59–64. doi: 10.1016/0002-9343(87)90378-0. [DOI] [PubMed] [Google Scholar]
- Shah P., Dhurjon L., Metcalfe T., Gibson J. M. Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol. BMJ. 1992 Jan 4;304(6818):40–41. doi: 10.1136/bmj.304.6818.40. [DOI] [PMC free article] [PubMed] [Google Scholar]